期刊文献+

胸腺肽α_1的温度诱导原核可溶性表达与简易纯化 被引量:3

Thermo-inductively Prokaryotic Expression in a Soluble Form and Easy Purification of Thymosin α_1
下载PDF
导出
摘要 将人工合成的人胸腺肽α1(Tα1)基因插入到载体pBV222,转化大肠杆菌DH5α菌株并置42℃诱导表达可溶性融合蛋白。融合蛋白经镍亲和层析柱纯化,加入肠激酶切割,再将酶切反应体系回到镍亲和层析柱。所获穿过液中的重组胸腺肽α1(rTα1),经十二烷基硫酸钠-聚苯烯酰胺凝胶电泳(SDS-PAGE)和反相高效液相色谱(RP-HPLC)分离及分析,纯度分别为94.5%和72%。以癌症患者外周血淋巴细胞开展玫瑰花环试验,所获rTα1纯品显示出与化学合成Tα1(sTα1)相同的生物学活性。 An artificially synthesized gene of human thymosin α1(Tα1) was inserted into pBV222 and then thermo-inductively expressed as a fusion protein in a soluble form in transformed Escherichia coli strain DH5α at 42°C.The fusion protein purified through nickel affinity chromatography was cleaved with enterokinase.The cleavage mixture was returned to the nickel affinity chromatography column.Recombinant Tα1(rTα1) in the flow-through reached a purity of 94.5% as showed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis(SDS-PAGE) and 72% by reverse phase-high performance liquid chromatography(RP-HPLC),respectively.The finally purified rTα1 exhibited the same bioactivity as chemically synthesized Tα1 in rosette tests with peripheral blood lymphocytes from cancer patients.
出处 《云南农业大学学报(自然科学版)》 CAS CSCD 北大核心 2012年第2期183-187,共5页 Journal of Yunnan Agricultural University:Natural Science
基金 云南农业大学博士科研启动经费资助项目(A2002094)
关键词 胸腺肽Α1 原核表达系统 镍亲和层析 反相高效液相色谱 玫瑰花环试验 thymosin α1 prokaryotic expression system nickel affinity chromatography reverse phase high performance liquid chromatography rosette test
  • 相关文献

参考文献22

  • 1ROMANI L,BISTONI F,MONTAGNOLI C,et al.Thy-mosin alpha1:an endogenous regulator of inflammation,immunity,and tolerance[J].Annals of the New YorkAcademy of Sciences,2007,1112(1):326-338.
  • 2YAO Q Z,DOAN L X,ZHANG R X,et al.Thymosin-alpha1 modulates dendritic cell differentiation and func-tional maturation from human peripheral blood CD14+monocytes[J].Immunology Letters,2007,110(2):110-120.
  • 3NAYLOR P H,QUADRINI K,GARACI E,et al.Im-munopharmacology of thymosin alpha1 and cytokine syn-ergy[J].Annals of the New York Academy of Sciences,2007,1112(1):235-244.
  • 4LI J,LIU C H,WANG F S.Thymosin alpha 1:biologi-cal activities,applications and genetic engineering pro-duction[J].Peptides,2010,31(11):2151-2158.
  • 5CHEN P F,FU G F,ZHANG H Y,et al.Liposomalplasmid DNA encoding human thymosin alpha and inter-feron omega potently inhibits liver tumor growth in ICRmice[J].Journal of Gastroenterology and Hepatology,2006,21(10):1538-1543.
  • 6JIANG Y F,MA Z H,ZHAO P W,et al.Effect of thy-mosin-α(1)on T-helper 1 cell and T-helper 2 cell cyto-kine synthesis in patients with hepatitis B virus e antigen-positive chronic hepatitis B[J].The Journal of Interna-tional Medical Research,2010,38(6):2053-2062.
  • 7SHERMAN K E.Thymosin alpha 1 for treatment of hepa-titis C virus:promise and proof[J].Annals of the NewYork Academy of Sciences,2010,1194(1):136-140.
  • 8GARACI E,PICA F,SINIBALDI-VALLEBONA P,etal.Thymosin alpha(1)in combination with cytokinesand chemotherapy for the treatment of cancer[J].Inter-national Immunopharmacology,2003,3(8):1145-1150.
  • 9NAYLOR P H,HADDEN J W.Preclinical studies withIRX-2 and thymosin alpha1 in combination therapy[J].Annals of the New York Academy of Sciences,2010,1194(1):162-168.
  • 10GOLDSTEIN A L.From lab to bedside:emerging clini-cal applications of thymosin alpha 1[J].Expert Opin-ion on Biological Therapy,2009,9(5):593-608.

二级参考文献42

共引文献31

同被引文献40

  • 1赫捷,陈万青主编.2012中国肿瘤登记年报.第1版.北京:军事医学科学出版社,2012.72.
  • 2Go|dstein AL, Slater FD, White A. Preparation, assay, and par- tial purification of a thymic lymphocytopoietic factor (thymosin) [J]. Proc Natl Acad Sci USA, 1966, 56 (3): 1010-1017.
  • 3Elizondo-Riojas MA, Chamow SM, Tuthill CW, et aL NMR structure of human thymosin alpha-1 [J]. Biochem Biophys Res Commun, 2011, 416 (3-4): 356-361.
  • 4Goldstcin AL, Low TL, McAdoo M, et al. Thymosin alpha 1: isolation and sequence analysis of an immunologically active thymic peptide [J]. Proc Natl Acad Sci USA, 1977, 74 (2):725-729.
  • 5Sandra K, Moshir M, D'hondt F, et al. Highly efficient peptide separations in proteomics. Part 2: bi- and multidimensional liq- uid-based separation techniques [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2009, 877 (11-12): 1019-1039.
  • 6Di Palma S, Hennrich ML, Heck AJ, et ol. Recent advances in peptide separation by multidimensional liquid chromatography for proteome analysis [J]. J Proteomics, 2012, 75 (13): 3791- 3813.
  • 7徐晓,吉春,熊国裕.一种合成胸腺肽α1的分离纯化方法[P]:中国,CN102477094A.
  • 8F61ix G, Joly P, Droux S, et ol. Purification studies of thymosin c-I in LC [J]. ChromatogTaphia, 2009, 70 (3-4): 381-387.
  • 9Li J, Liu CH, Wang FS. Thymosin alpha 1: biological activities, applications and genetic engineering production [J]. Peptides, 2010, 31(11): 2151-2158.
  • 10Li WN, Song LQ, Wu SZ, et cd. Expression, purification and eharaeterization of a novel soluble human thymosin alphal con- eatemer exhibited a stronger stimulation on miee lymphocytes proliferation and higher anti-tumor activity [J]. Int J Biol Sei, 2011, 7 (5): 618-628.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部